Helen I. Torley
2021
Compensation breakdown
| Non-Equity Incentive Plan | $807,619 |
|---|---|
| Option Awards | $1,740,001 |
| Salary | $830,221 |
| Stock Awards | $4,060,081 |
| Other | $15,372 |
| Total | $7,453,294 |
Torley received $4.1M in stock awards, accounting for 54% of the total pay in 2021.
Torley also received $807.6K in non-equity incentive plan, $1.7M in option awards, $830.2K in salary and $15.4K in other compensation.
Rankings
In 2021, Helen I. Torley's compensation ranked 1,593rd out of 12,405 executives tracked by ExecPay. In other words, Torley earned more than 87.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,593 out of 12,405 | 87th |
Division Manufacturing | 579 out of 5,494 | 90th |
Major group Chemicals And Allied Products | 214 out of 2,369 | 91st |
Industry group Drugs | 179 out of 2,090 | 91st |
Industry Biological Products, Except Diagnostic Substances | 50 out of 452 | 89th |
Pay ratio
| Helen I. Torley's Pay | $7,453,294 |
|---|---|
| Median Employee's Pay | $291,734 |
| Pay Ratio | 26to 1 |
In 2021, the annual total compensation of Helen I. Torley was $7,453,294.
The annual total compensation of the median employee at Halozyme Therapeutics was $291,734.
The ratio of Helen I. Torley's pay to the pay of median employee was therefore 26 to one.
Torley's colleagues
We found three more compensation records of executives who worked with Helen I. Torley at Halozyme Therapeutics in 2021.
News
March 25, 2022
March 26, 2021
March 20, 2020
March 22, 2019